Japan· JP-2499417G1023
パシレオチドパモ酸塩
A medicinal product containing パシレオチドパモ酸塩, registered in Japan by レコルダティ・レア・ディジーズ・ジャパン, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- パシレオチドパモ酸塩
- Manufacturer
- レコルダティ・レア・ディジーズ・ジャパン
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
パシレオチドパモ酸塩 in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSIGNIFOR 0,3 MG SOLUCION INYECTABLERecordati Rare Diseases
- PolandSigniforRecordati Rare Diseases
- SwedenSignifor 0,3 mg Injektionsvätska, lösningRecordati Rare Diseases
- IrelandSignifor 0.3 mg solution for injectionRecordati Rare Diseases
- IcelandSigniforRecordati Rare Diseases*
- NetherlandsSignifor 0,3 mg oplossing voor injectieRecordati Rare Diseases
- CanadaSIGNIFORRECORDATI RARE DISEASES CANADA INC
- SwitzerlandSignifor 0.3 mg/1 ml, InjektionslösungRECORDATI AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Signifor
- Liechtenstein · Signifor
- Norway · Signifor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/182fdd02-5130-4d8f-b96c-31367da873ea GET /v1/drugs/182fdd02-5130-4d8f-b96c-31367da873ea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２０ｍｇ１キット（溶解液付）",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2499417G1023",
"category": "注射薬",
"price_yen": 196787,
"generic_name": "パシレオチドパモ酸塩",
"product_name_jp": null,
"therapeutic_class": "2499",
"transitional_expiry": null
}See everything about パシレオチドパモ酸塩.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.